Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "drug discovery", collected in one continuously updated archive.
Gero has secured $17 million in new funding, bringing its total capital raised to $34 million as the company advances AI-driven drug discovery focused on aging and chronic diseases.
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
Recursion Pharmaceuticals, Inc. is an American clinical-stage biotechnology company that uses automated experiments, biological datasets, computing, and machine learning in drug discovery. It develops its own medicine candidates and conducts research programs with pharmaceutical partners.